WASHINGTON — Pfizer-BioNTech asked for authorization Friday to use their COVID-19 vaccine on 12 to 15-year-olds in the United States, which could mark a crucial next step toward achieving herd immunity.
The mass vaccination of teenagers would also relieve an enormous strain on parents who are juggling the demands of homeschooling their children while keeping up with jobs.
The companies said in a statement that they plan to make similar requests of other regulatory authorities worldwide in coming days.
Their request to the US Food and Drug Administration comes after Phase 3 clinical trials of the Pfizer vaccine in 12 to 15-year-olds showed it was 100 percent effective in wa…
Keep on reading: Pfizer seeks COVID-19 vaccine OK for 12 to 15 year olds in US